In malignant glioma with primitive neuroectodermal components (MG-PNET), a rare type of brain tumor that most likely develops from already existing glioma, about half of the patients demonstrate mutually exclusive MYC or MYCN amplifications (26). This evidence concerns the gene MYCN and central nervous system cancer.